Peptide Reports

AOD-9604

Community Protocol

AOD-9604

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Educational and calculation-reference material only. Community reports are uncontrolled anecdotes and do not replace professional medical guidance, product labeling, or individualized clinical monitoring.

Scope

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Available strengths: 10 MG

Preparation Examples

These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.

SetupDiluentConcentrationUnit conversion
10 MG vial – 2 mL exampleAdd 2 mL supplied acetic-acid water (AA water)5 mg/mLEach U-100 unit = 50 mcg
10 MG vial – 1 mL exampleAdd 1 mL supplied acetic-acid water (AA water)10 mg/mLEach U-100 unit = 100 mcg

Syringe Conversion

Reported amount10 MG setup10 MG setup
100 mcg2 units1 units
250 mcg5 units2.5 units
300 mcg6 units3 units
500 mcg10 units5 units

Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.

Community-Reported Patterns

Recurring reportFrequency seenContext in reports
250 mcgOnce dailyLower recurring amount
300 mcgOnce dailyMost repeated amount reviewed
500 mcgOnce dailyHigher community reports

Observations

  • Community discussions most often centered on fat-loss and body-composition goals.
  • The amount, frequency, route and cycle length varied substantially between reports.
  • Reported outcomes were commonly confounded by diet, training, other products or existing treatment.

Caveats

  • AOD-9604 is not an approved weight-loss medication, and online outcomes do not establish benefit or safety. Confirm the product form and the labeled acetic-acid concentration because peptide formulation and aggregation are sensitive to pH and manufacturing conditions.
  • Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.

Sources

  1. FDA Pharmacy Compounding Advisory Committee review: AOD-9604
  2. Community search: AOD-9604
  3. PubMed literature search: AOD-9604